Felton Timothy, Pattison Natalie, Fletcher Simon, Finney Simon, Walsh Tim, Dark Paul
Acute Intensive Care Unit, Wythenshawe Hospital, Manchester University Foundation Trust, Manchester, UK.
School of Health and Social Work, University of Hertfordshire, Hatfield, Hertfordshire, UK.
J Intensive Care Soc. 2022 Feb;23(1):53-57. doi: 10.1177/1751143720971542. Epub 2020 Nov 8.
In 2013, a group of clinicians on behalf of the National Institute for Health Research, collaborated with ICU Steps to produce guidance about people being enrolled in more than one critical care trial. This is referred to as "co-enrolment" and can be where a person takes part in one study at the same time as another study (or one after the other in a short time-frame). For instance, being part of a study looking at sepsis drugs and a mechanical ventilation weaning study. The drivers for developing this guidance were a lack of any existing guidance, nationally and internationally, at that time, and a desire to ensure high quality research is conducted. The emphasis was on making trials as safe as possible for patients and ensuring robust trial outcomes. Critical care was seen to lead in this, with our exemplar guidance used across all health research. We wish to revisit this guidance now that there is more experience of coenrolment in critical care trials. There is also more awareness of different consent models, such as deferred consent (taking consent when a person is awake and able to give consent) and consultee consent (asking families or independent professionals to consent). Consenting to coenrolment is an important ethical consideration for the revision of this guidance.
2013年,一群代表英国国家卫生研究院的临床医生与重症监护步骤组织合作,制定了关于人们参与多项重症监护试验的指南。这被称为“共同入组”,可能是一个人同时参与一项研究和另一项研究(或者在短时间内先后参与两项研究)。例如,参与一项关于脓毒症药物的研究和一项机械通气撤机研究。制定该指南的原因是当时国内和国际上都缺乏任何现有的指南,并且希望确保开展高质量的研究。重点是使试验对患者尽可能安全,并确保试验结果可靠。重症监护在这方面被视为引领者,我们的范例指南在所有健康研究中都被采用。鉴于现在在重症监护试验中有了更多共同入组的经验,我们希望重新审视该指南。对于不同的同意模式也有了更多认识,比如延迟同意(在一个人清醒且能够给予同意时获取同意)和咨询同意(要求家属或独立专业人员同意)。同意共同入组是修订本指南的一个重要伦理考量。